Drugs / Xiyanping
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02937857 | Aug 2016 → Apr 2020 | bronchitis | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Unknown | No outcome recorded |
| Phase not applicable6 trials | ||||||
| — | NCT04296383 | Jun 2020 → Aug 2021 | Mycoplasma pneumoniae pneumonia | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Unknown | No outcome recorded |
| — | NCT04295551 | Mar → Jul 2020 | COVID-19 | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Unknown | No outcome recorded |
| — | NCT03947411 | Mar 2019 → Mar 2020 | influenza | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Unknown | No outcome recorded |
| — | NCT02069665 | Dec 2011 → Jul 2013 | pneumonia | Liaoning University of Traditional Chinese Medicine | Completed | No outcome recorded |
| — | NCT01182025 | Jun 2010 → May 2011 | hand, foot and mouth disease | The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine | Unknown | No outcome recorded |
| — | NCT01554930 | May → Nov 2010 | hand, foot and mouth disease | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiyanping | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01182025 ↗ |
| Route | Intravenous | “Xiyanping injection:5-10mg/kg/d (0.2-0.4ml/kg/d),qd ivgtt” NCT01554930 ↗ |